Is there any optimum value of lepidic parameters for cancer risk and progress?
Clin Nutr
.
2019 Feb;38(1):478-479.
doi: 10.1016/j.clnu.2018.11.004.
Epub 2018 Nov 16.
Author
Albert Boretti
1
Affiliation
1
14 Chancellor Avenue, Bundoora, 3083, VIC, Australia. Electronic address: a.a.boretti@gmal.com.
PMID:
30473443
DOI:
10.1016/j.clnu.2018.11.004
No abstract available
Publication types
Letter
Review
MeSH terms
Cholesterol / adverse effects
Cholesterol / blood*
Humans
Neoplasms / blood*
Neoplasms / epidemiology*
Risk
Substances
Cholesterol